RSV Vaccines in Adults: A Risk-Based Approach
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
RSV Vaccines in Adults: A Risk-Based Approach
-
Narrado por:
-
De:
In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including:
- Current Advisory Committee on Immunization Practices recommendations
- Risk factors associated with severe RSV disease, including RSV-related hospitalizations
- Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine
- Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities
- Health disparities related to RSV vaccines
- Considerations for a risk-based approach, rather than age alone, to determine vaccine candidacy
Faculty:
Angela Branche, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York
Link to full program:
https://bit.ly/3nb25xe
Link to downloadable slides:
https://bit.ly/3TsXym5
Todavía no hay opiniones